NIMBLE is developing the first medical device to monitor patients with implanted stents
NIMBLE Diagnostics has raised €1.0M across 1 funding round from 3 investors, most recently a round in Jan 2023. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-18 | Other | €1.0M |
| Grow Ventures,Inveniam Group,Namarel Ventures |
| View deal → |
